Infectious disease | R-HSA-5663205 | 4.47 |
Host Interactions of HIV factors | R-HSA-162909 | 5.99 |
MHC class II antigen presentation | R-HSA-2132295 | 6.01 |
Immune System | R-HSA-168256 | 2.37 |
HIV Infection | R-HSA-162906 | 5.22 |
Clathrin derived vesicle budding | R-HSA-421837 | 6.85 |
Membrane Trafficking | R-HSA-199991 | 5.26 |
trans-Golgi Network Vesicle Budding | R-HSA-199992 | 6.85 |
Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 7.23 |
Lysosome Vesicle Biogenesis | R-HSA-432720 | 7.85 |
The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 8.18 |
Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 9.66 |
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.59 |
Adaptive Immune System | R-HSA-1280218 | 3.19 |
Disease | R-HSA-1643685 | 3.33 |
Vesicle-mediated transport | R-HSA-5653656 | 4.33 |